Rubicin

Generic Name: Doxorubicin Hydrochloride
Strength: 20 mg
Dosage Form: Injection (Lyophilized powder or solution for reconstitution)
Route of Administration: Intravenous (IV)

Description:

Rubicin 20 mg Injection contains doxorubicin hydrochloride, an anthracycline antibiotic with potent antineoplastic (anticancer) activity. It works primarily through DNA intercalation and inhibition of topoisomerase II, leading to disruption of DNA replication and cell death.

Indications:

• Breast cancer

• Lung cancer

• Ovarian cancer

• Lymphomas (Hodgkin’s and non-Hodgkin’s)

• Leukemias

• Sarcomas

• Bladder cancer

• Thyroid cancer

• Other solid tumors

Key Features:

• Broad-spectrum anticancer agent

• Used as part of various chemotherapy regimens

• May be used alone or in combination therapy

Dosage & Administration:

• Administered intravenously under the supervision of an experienced oncologist.

• Dosage varies according to the treatment protocol, cancer type, and patient condition.

• Adequate hydration and monitoring are essential during administration.

Precautions:

• Risk of cardiotoxicity (especially cumulative doses)

• Myelosuppression (decreased blood cell counts)

• Extravasation may cause severe tissue damage

• Hepatic function monitoring required

• Pregnancy Category D: Contraindicated in pregnancy unless benefits outweigh risks

Adverse Effects:

• Nausea and vomiting

• Hair loss (alopecia)

• Bone marrow suppression

• Cardiotoxicity (arrhythmias, cardiomyopathy)

• Mucositis

• Fatigue

• Red discoloration of urine

Storage:

• Store below 25°C, protected from light.

• Reconstituted solutions should be used promptly or stored as per manufacturer's instructions.